Cargando…
What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature
Liver disease is one of the most common extraintestinal manifestations of inflammatory bowel disease (IBD). Often the course of liver disease is associated with an exacerbation of the underlying disease (Crohn’s Disease/Ulcerative Colitis). Nonalcoholic steatohepatitis encompasses a wide spectrum of...
Autores principales: | Jarmakiewicz-Czaja, Sara, Gruszecka, Jolanta, Filip, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051776/ https://www.ncbi.nlm.nih.gov/pubmed/36984818 http://dx.doi.org/10.3390/metabo13030378 |
Ejemplares similares
-
What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2020) -
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022) -
TiO(2) – do we have to worry about it? One of the important aetiological factors in inflammatory bowel disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2021) -
The Influence of Nutrients on Inflammatory Bowel Diseases
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2020) -
Antioxidants as Protection against Reactive Oxidative Stress in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2023)